Register for the 2023 SOSV Climate Tech Summit on Sept. 26-27.

OaCP IE LTD

Accelerating cancer diagnostics, precision medicine, and personal genomics

Team

Enrico Di Oto

CEO & Founder

Allegro Mateo

CCO & Co-founder

Andrea Faviere

CMO & Co-founder

Eros Matteo Venturini

Laboratory Technician & Co-Founder

Francesco Villa

CFO & Co-Founder

Company details

OACP is a “fast reagents” company with reagents that are 18% faster, available in quantity, and less expensive than reagents used by the U.S. FDA and CDC. OACP can provide 100,000 tests per week with a 1 hour 6 min turnaround time using standard qPCR processing, which is 18% faster than CDC tests, roughly 45% faster than the ~2 hr South Korean test, and significantly faster than some other reagents that take up to 2.5 hours.The cost is approximately $14/test for PCR reagents (excluding extraction of RNA costs). The tests can be ordered by the tens of thousands with a 5-day turnaround.

Get In Touch with OaCP IE LTD

Please tell us a little bit about yourself and why you'd like to get connected. OaCP IE LTD + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.